Why the study?
Are cardiac troponin T concentrations measured with a highly sensitive assay associated with cardiovascular death, heart failure, or myocardial infarction in patients with stable coronary artery disease?
Are cardiac troponin T concentrations measured with a highly sensitive assay associated with cardiovascular death, heart failure, or myocardial infarction in patients with stable coronary artery disease?
Highly sensitive cardiac troponin T is a significant prognostic marker for cardiovascular death and heart failure in patients with stable coronary artery disease.
hs-cTnT may refine risk stratification for CV death and HF in stable CAD; leaves open therapeutic implications and needs prospective validation.
After adjustment for other independent prognostic indicators, cardiac troponin T concentrations as measured with a highly sensitive assay were significantly associated with the incidence of cardiovascular death and heart failure but not with myocardial infarction in patients with stable coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Omland et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: